Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
The current price of DGX is $195.21 USD — it has increased by +0.72% in the past 24 hours. Watch Quest Diagnostics stock price performance more closely on the chart.
What is Quest Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quest Diagnostics stocks are traded under the ticker DGX.
Is Quest Diagnostics stock price growing?▼
DGX stock has risen by +2.53% compared to the previous week, the month change is a -0.54% fall, over the last year Quest Diagnostics has showed a +14% increase.
What is Quest Diagnostics market cap?▼
Today Quest Diagnostics has the market capitalization of 21.45B
When is the next Quest Diagnostics earnings date?▼
Quest Diagnostics is going to release the next earnings report on July 28, 2026.
What were Quest Diagnostics earnings last quarter?▼
DGX earnings for the last quarter are 2.5 USD per share, whereas the estimation was 2.37 USD resulting in a +5.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quest Diagnostics revenue for the last year?▼
Quest Diagnostics revenue for the last year amounts to 22.07B USD.
What is Quest Diagnostics net income for the last year?▼
DGX net income for the last year is 1.98B USD.
Does Quest Diagnostics pay dividends?▼
Yes, DGX dividends are paid quarterly. The last dividend per share was 0.86 USD. As of today, Dividend Yield (FWD)% is 1.76%.
How many employees does Quest Diagnostics have?▼
As of May 26, 2026, the company has 55,000 employees.
In which sector is Quest Diagnostics located?▼
Quest Diagnostics operates in the Health & Wellness sector.
When did Quest Diagnostics complete a stock split?▼
The last stock split for Quest Diagnostics was on June 21, 2005 with a ratio of 2:1.
Where is Quest Diagnostics headquartered?▼
Quest Diagnostics is headquartered in Secaucus, United States.